{"id":19237,"date":"2025-07-02T17:47:38","date_gmt":"2025-07-02T20:47:38","guid":{"rendered":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/advanced-2-tara-002-101-cancer-de-bexiga-musculo-nao-invasivo-de-alto-grau\/"},"modified":"2025-07-02T17:47:38","modified_gmt":"2025-07-02T20:47:38","slug":"advanced-2-tara-002-101-cancer-de-bexiga-musculo-nao-invasivo-de-alto-grau","status":"publish","type":"ensaio_clinico","link":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/pesquisa\/ensaiosclinicos\/advanced-2-tara-002-101-cancer-de-bexiga-musculo-nao-invasivo-de-alto-grau\/","title":{"rendered":"ADVANCED-2 (TARA-002-101) &#8211; C\u00e2ncer de bexiga m\u00fasculo n\u00e3o invasivo de alto grau"},"content":{"rendered":"<div data-olk-copy-source=\"MessageBody\">Avaliar a seguran\u00e7a e a atividade antitumoral de TARA-002 intravesical em adultos.<\/div>\n<div><b>&nbsp;<\/b><\/div>\n<div><b>Popula\u00e7\u00e3o:&nbsp;<\/b>Confirma\u00e7\u00e3o histol\u00f3gica central de CIS (\u00b1 Ta\/T1) m\u00fasculo n\u00e3o invasivo de alto grau com doen\u00e7a ativa.&nbsp;<u>Coorte B<\/u>: CIS (\u00b1 Ta\/T1) persistente ou recorrente dentro de 12 meses ap\u00f3s a conclus\u00e3o da terapia com BCG adequada (pelo menos 5 de 6 doses de um curso de indu\u00e7\u00e3o inicial mais, no m\u00ednimo, 2 de 3 doses de terapia de manuten\u00e7\u00e3o ou pelo menos 2 de 6 doses de reindu\u00e7\u00e3o). ECOG 0 a 2.<\/div>\n<div>&nbsp;<\/div>\n<div><span data-olk-copy-source=\"MessageBody\">ClinicalTrials.gov: NCT05951179<\/span><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Avaliar a seguran\u00e7a e a atividade antitumoral de TARA-002 intravesical em adultos. &nbsp; Popula\u00e7\u00e3o:&nbsp;Confirma\u00e7\u00e3o histol\u00f3gica central de CIS (\u00b1 Ta\/T1) m\u00fasculo n\u00e3o invasivo de alto grau com doen\u00e7a ativa.&nbsp;Coorte B: CIS (\u00b1 Ta\/T1) persistente ou recorrente dentro de 12 meses ap\u00f3s a conclus\u00e3o da terapia com BCG adequada (pelo menos 5 de 6 doses de [&hellip;]<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false},"class_list":["post-19237","ensaio_clinico","type-ensaio_clinico","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ADVANCED-2 (TARA-002-101) - C\u00e2ncer de bexiga m\u00fasculo n\u00e3o invasivo de alto grau - IDOR - Instituto D&#039;Or de Pesquisa e Ensino<\/title>\n<link rel=\"canonical\" href=\"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/advanced-2-tara-002-101-cancer-de-bexiga-musculo-nao-invasivo-de-alto-grau\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ADVANCED-2 (TARA-002-101) - C\u00e2ncer de bexiga m\u00fasculo n\u00e3o invasivo de alto grau - IDOR - Instituto D&#039;Or de Pesquisa e Ensino\" \/>\n<meta property=\"og:description\" content=\"Avaliar a seguran\u00e7a e a atividade antitumoral de TARA-002 intravesical em adultos. &nbsp; Popula\u00e7\u00e3o:&nbsp;Confirma\u00e7\u00e3o histol\u00f3gica central de CIS (\u00b1 Ta\/T1) m\u00fasculo n\u00e3o invasivo de alto grau com doen\u00e7a ativa.&nbsp;Coorte B: CIS (\u00b1 Ta\/T1) persistente ou recorrente dentro de 12 meses ap\u00f3s a conclus\u00e3o da terapia com BCG adequada (pelo menos 5 de 6 doses de [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/advanced-2-tara-002-101-cancer-de-bexiga-musculo-nao-invasivo-de-alto-grau\/\" \/>\n<meta property=\"og:site_name\" content=\"IDOR - Instituto D&#039;Or de Pesquisa e Ensino\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/advanced-2-tara-002-101-cancer-de-bexiga-musculo-nao-invasivo-de-alto-grau\\\/\",\"url\":\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/advanced-2-tara-002-101-cancer-de-bexiga-musculo-nao-invasivo-de-alto-grau\\\/\",\"name\":\"ADVANCED-2 (TARA-002-101) - C\u00e2ncer de bexiga m\u00fasculo n\u00e3o invasivo de alto grau - IDOR - Instituto D&#039;Or de Pesquisa e Ensino\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ptbr.idor.org\\\/#website\"},\"datePublished\":\"2025-07-02T20:47:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/advanced-2-tara-002-101-cancer-de-bexiga-musculo-nao-invasivo-de-alto-grau\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/advanced-2-tara-002-101-cancer-de-bexiga-musculo-nao-invasivo-de-alto-grau\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/advanced-2-tara-002-101-cancer-de-bexiga-musculo-nao-invasivo-de-alto-grau\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/ptbr.idor.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ensaios Cl\u00ednicos\",\"item\":\"https:\\\/\\\/ptbr.idor.org\\\/pesquisa\\\/ensaiosclinicos\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"ADVANCED-2 (TARA-002-101) &#8211; C\u00e2ncer de bexiga m\u00fasculo n\u00e3o invasivo de alto grau\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ptbr.idor.org\\\/#website\",\"url\":\"https:\\\/\\\/ptbr.idor.org\\\/\",\"name\":\"IDOR - Instituto D&#039;Or de Pesquisa e Ensino\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ptbr.idor.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ADVANCED-2 (TARA-002-101) - C\u00e2ncer de bexiga m\u00fasculo n\u00e3o invasivo de alto grau - IDOR - Instituto D&#039;Or de Pesquisa e Ensino","canonical":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/advanced-2-tara-002-101-cancer-de-bexiga-musculo-nao-invasivo-de-alto-grau\/","og_locale":"pt_BR","og_type":"article","og_title":"ADVANCED-2 (TARA-002-101) - C\u00e2ncer de bexiga m\u00fasculo n\u00e3o invasivo de alto grau - IDOR - Instituto D&#039;Or de Pesquisa e Ensino","og_description":"Avaliar a seguran\u00e7a e a atividade antitumoral de TARA-002 intravesical em adultos. &nbsp; Popula\u00e7\u00e3o:&nbsp;Confirma\u00e7\u00e3o histol\u00f3gica central de CIS (\u00b1 Ta\/T1) m\u00fasculo n\u00e3o invasivo de alto grau com doen\u00e7a ativa.&nbsp;Coorte B: CIS (\u00b1 Ta\/T1) persistente ou recorrente dentro de 12 meses ap\u00f3s a conclus\u00e3o da terapia com BCG adequada (pelo menos 5 de 6 doses de [&hellip;]","og_url":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/advanced-2-tara-002-101-cancer-de-bexiga-musculo-nao-invasivo-de-alto-grau\/","og_site_name":"IDOR - Instituto D&#039;Or de Pesquisa e Ensino","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/advanced-2-tara-002-101-cancer-de-bexiga-musculo-nao-invasivo-de-alto-grau\/","url":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/advanced-2-tara-002-101-cancer-de-bexiga-musculo-nao-invasivo-de-alto-grau\/","name":"ADVANCED-2 (TARA-002-101) - C\u00e2ncer de bexiga m\u00fasculo n\u00e3o invasivo de alto grau - IDOR - Instituto D&#039;Or de Pesquisa e Ensino","isPartOf":{"@id":"https:\/\/ptbr.idor.org\/#website"},"datePublished":"2025-07-02T20:47:38+00:00","breadcrumb":{"@id":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/advanced-2-tara-002-101-cancer-de-bexiga-musculo-nao-invasivo-de-alto-grau\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/advanced-2-tara-002-101-cancer-de-bexiga-musculo-nao-invasivo-de-alto-grau\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/advanced-2-tara-002-101-cancer-de-bexiga-musculo-nao-invasivo-de-alto-grau\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/ptbr.idor.org\/"},{"@type":"ListItem","position":2,"name":"Ensaios Cl\u00ednicos","item":"https:\/\/ptbr.idor.org\/pesquisa\/ensaiosclinicos\/"},{"@type":"ListItem","position":3,"name":"ADVANCED-2 (TARA-002-101) &#8211; C\u00e2ncer de bexiga m\u00fasculo n\u00e3o invasivo de alto grau"}]},{"@type":"WebSite","@id":"https:\/\/ptbr.idor.org\/#website","url":"https:\/\/ptbr.idor.org\/","name":"IDOR - Instituto D&#039;Or de Pesquisa e Ensino","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ptbr.idor.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"}]}},"_links":{"self":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/ensaio_clinico\/19237","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/ensaio_clinico"}],"about":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/types\/ensaio_clinico"}],"wp:attachment":[{"href":"https:\/\/www.rededorsaoluiz.com.br\/instituto\/idor\/wp-json\/wp\/v2\/media?parent=19237"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}